Chiasma, Inc. (CHMA) Stock Analysis
DELISTED
What happened to Chiasma, Inc. (CHMA) stock?
Chiasma, Inc. (CHMA) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Chiasma, Inc. (CHMA). Chiasma, Inc. is a clinical late-stage biopharmaceutical company focused on developing oral medications for rare chronic diseases. Its lead product, MYCAPSSA, targets acromegaly and is currently in Phase III clinical trials.
Last analyzed: May 10, 2026Chiasma, Inc. (CHMA) Healthcare & Pipeline Overview
More about this archive record
Can I still buy CHMA shares?
No. CHMA stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CHMA elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CHMA stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Chiasma, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.